BR9205939A - Derivados de 4-aril-3-(heteroalilureído)quinolina - Google Patents

Derivados de 4-aril-3-(heteroalilureído)quinolina

Info

Publication number
BR9205939A
BR9205939A BR9205939A BR9205939A BR9205939A BR 9205939 A BR9205939 A BR 9205939A BR 9205939 A BR9205939 A BR 9205939A BR 9205939 A BR9205939 A BR 9205939A BR 9205939 A BR9205939 A BR 9205939A
Authority
BR
Brazil
Prior art keywords
heteroalylureido
quinoline
aryl
derivatives
Prior art date
Application number
BR9205939A
Other languages
English (en)
Portuguese (pt)
Inventor
Ernest S Hamanaka
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of BR9205939A publication Critical patent/BR9205939A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
BR9205939A 1991-04-26 1992-03-16 Derivados de 4-aril-3-(heteroalilureído)quinolina BR9205939A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69232391A 1991-04-26 1991-04-26
PCT/US1992/001801 WO1992019614A1 (en) 1991-04-26 1992-03-16 4-aryl-3-(heteroarylureido)quinoline derivatives

Publications (1)

Publication Number Publication Date
BR9205939A true BR9205939A (pt) 1994-09-27

Family

ID=24780107

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9205939A BR9205939A (pt) 1991-04-26 1992-03-16 Derivados de 4-aril-3-(heteroalilureído)quinolina

Country Status (20)

Country Link
EP (1) EP0590094A1 (de)
JP (1) JPH0776215B2 (de)
CN (1) CN1066068A (de)
AU (1) AU1879792A (de)
BR (1) BR9205939A (de)
CA (1) CA2108014A1 (de)
CZ (1) CZ395592A3 (de)
DE (1) DE9290049U1 (de)
FI (1) FI934710A0 (de)
HU (1) HUT65748A (de)
IE (1) IE921330A1 (de)
IL (1) IL101627A0 (de)
MX (1) MX9201916A (de)
NO (1) NO933837L (de)
NZ (1) NZ242493A (de)
PT (1) PT100426A (de)
TW (1) TW197436B (de)
WO (1) WO1992019614A1 (de)
YU (1) YU44592A (de)
ZA (1) ZA922976B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2125325T3 (es) * 1992-01-23 1999-03-01 Pfizer Derivados de 4-fenil-3-(heteroarilureido)-1,2-dihidro-2-oxoquinolina como agentes antihipercolesterolemicos y antiateroscleroticos.
US5565472A (en) * 1992-12-21 1996-10-15 Pfizer Inc. 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents
NZ264063A (en) * 1993-08-13 1995-11-27 Nihon Nohyaku Co Ltd N-(2-phenylpyrid-3-yl)- and n-(4-phenylpyrimidin-5-yl)-n'-phenylurea derivatives and pharmaceutical compositions
US5843957A (en) * 1995-05-19 1998-12-01 Sumitomo Pharmaceuticals Company, Ltd. Naphthyridine derivatives
EP0842933B1 (de) * 1995-05-31 2004-08-04 Sumitomo Pharmaceuticals Company, Limited Neue naphthyridinderivate.
CN1245500A (zh) * 1996-11-26 2000-02-23 住友制药株式会社 新型萘啶衍生物
US6452008B2 (en) 1998-02-25 2002-09-17 Sumitomo Pharmaceuticals Company, Limited Pyridone derivatives and process for preparing the same
CA2321237A1 (en) 1998-02-25 1999-09-02 Masami Muraoka Pyridone derivatives and process for producing the same
CA2547518A1 (en) 2003-12-12 2005-06-30 Wyeth Quinolines useful in treating cardiovascular disease
CN103601677B (zh) * 2013-11-19 2015-11-18 清华大学 制备2-烷硫基喹啉衍生物的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE892088L (en) * 1988-07-12 1990-01-12 William Henry Deryk Morris Quinoline derivatives, their production and use
WO1991004027A1 (en) * 1989-09-15 1991-04-04 Pfizer Inc. New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase (acat)
TW205037B (de) * 1989-10-06 1993-05-01 Takeda Pharm Industry Co Ltd

Also Published As

Publication number Publication date
YU44592A (sh) 1994-12-28
MX9201916A (es) 1992-11-01
AU1879792A (en) 1992-12-21
HUT65748A (en) 1994-07-28
WO1992019614A1 (en) 1992-11-12
ZA922976B (en) 1993-10-25
JPH06501025A (ja) 1994-01-27
NZ242493A (en) 1994-08-26
CA2108014A1 (en) 1992-10-27
EP0590094A1 (de) 1994-04-06
FI934710A (fi) 1993-10-25
PT100426A (pt) 1993-08-31
TW197436B (de) 1993-01-01
NO933837L (no) 1993-10-25
CN1066068A (zh) 1992-11-11
FI934710A0 (fi) 1993-10-25
JPH0776215B2 (ja) 1995-08-16
IL101627A0 (en) 1992-12-30
DE9290049U1 (de) 1994-01-05
CZ395592A3 (en) 1994-02-16
IE921330A1 (en) 1992-11-04
HU9303025D0 (en) 1994-01-28

Similar Documents

Publication Publication Date Title
DE69132519D1 (de) Quinolin-Derivate
DK0382185T3 (da) Carbostyrilderivater
DE68925405D1 (de) Carbostyril-Derivate
DE69208877D1 (de) Chinuclidinderivate
NO922182D0 (no) Krystallinske oksatiolan-derivater
ATA75293A (de) Indolderivate
DK0693478T3 (da) Quinolinforbindelser
FI925763A (fi) Fungicida 2-imidazolin-5-on- och 2-imidazolin-5-tionderivat
DK391189A (da) Carbostyrilderivater
DE69330497D1 (de) Chinazolin-derivate
DE59308714D1 (de) Cyclobutan-benzol-derivate
TR26336A (tr) SüBSTITüE EDILMIS PIRAZOLIN TüREVLERI
MX9205003A (es) Derivados novedosos de benzopirano.
NO930520D0 (no) Bifenyl-substituerte kinolinderivater
BR9205939A (pt) Derivados de 4-aril-3-(heteroalilureído)quinolina
DK81989A (da) Substituerede quinolinderivater
DK82189D0 (da) Substituerede quinolinderivater
FI944016A (fi) Makrolidien fluorisokerijohdannaiset
NO952288D0 (no) Benzazepinon-derivater
FI925469A (fi) Tiazolylsubstituerade kinolylymetoxifenylaettiksyraderivat
DE69313890T2 (de) 5-Aminoflavon-Derivate
MX9204370A (es) Derivados de pirazol.
MX9206710A (es) Derivados de piridinol
MX9102079A (es) Plemezcla de semduramicina
MX9205973A (es) Derivados de benzo-isoquinolinas.

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
FC Decision: refusal